Tech Company Financing Transactions

Elixir Pharmaceuticals Funding Round

MPM Capital, Arch Venture Partners and Novartis Venture Fund joined a $12 million funding round for Elixir Pharmaceuticals. The financing was recorded on 5/19/2009.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

300 Putnam Avenue
Cambridge, MA 02139
USA

Phone

(617) 995-7000

Website

www.elixirpharm.com

Email Address

[email protected]

Overview

Elixir Pharmaceuticals is a genomics-based drug discovery company developing a new category of pharmaceuticals that treat and/or prevent the broad spectrum of diseases that accompany aging.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Medical Officer

Paul Martha

        

Chief Scientific Officer

Peter DiStefano

        

VP - Finance

Karen Roberts

        

Browse more venture capital transactions:

Prev: 5/18/2009: Avila Therapeutics venture capital transaction
Next: 5/19/2009: Fulham venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary